Comment: possible interaction between nefazodone and pravastatin.
Bottorf
M B
MB
D000924:Anticholesteremic Agents / Q000494:pharmacology; D018687:Antidepressive Agents, Second-Generation / Q000494:pharmacology; D003402:Creatine Kinase / Q000378:metabolism*; D051544:Cytochrome P-450 CYP3A; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004347:Drug Interactions; D006801:Humans; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors / Q000378:metabolism; D010879:Piperazines; D017035:Pravastatin / Q000494:pharmacology*; D014230:Triazoles / Q000494:pharmacology*
D000924:Anticholesteremic Agents; D018687:Antidepressive Agents, Second-Generation; D065607:Cytochrome P-450 Enzyme Inhibitors; D010879:Piperazines; D014230:Triazoles; C051752:nefazodone; D003577:Cytochrome P-450 Enzyme System; D006899:Mixed Function Oxygenases; C104464:CYP3A protein, human; D051544:Cytochrome P-450 CYP3A; D003402:Creatine Kinase; D017035:Pravastatin